These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 39154855)

  • 1. Elucidating the harm potential of brorphine analogues as new synthetic opioids: Synthesis, in vitro, and in vivo characterization.
    Vandeputte MM; Bilel S; Tirri M; Corli G; Bassi M; Layle NK; Fantinati A; Walther D; Iula DM; Baumann MH; Stove CP; Marti M
    Neuropharmacology; 2024 Dec; 260():110113. PubMed ID: 39154855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative neuropharmacology of structurally distinct non-fentanyl opioids that are appearing on recreational drug markets worldwide.
    Vandeputte MM; Tsai MM; Chen L; Glatfelter GC; Walther D; Stove CP; Shi L; Baumann MH
    Drug Alcohol Depend; 2023 Aug; 249():109939. PubMed ID: 37276825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of recent non-fentanyl synthetic opioids via three different in vitro µ-opioid receptor activation assays.
    Vandeputte MM; Persson M; Walther D; Vikingsson S; Kronstrand R; Baumann MH; Gréen H; Stove CP
    Arch Toxicol; 2022 Mar; 96(3):877-897. PubMed ID: 35072756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro functional characterization of a panel of non-fentanyl opioid new psychoactive substances.
    Vandeputte MM; Cannaert A; Stove CP
    Arch Toxicol; 2020 Nov; 94(11):3819-3830. PubMed ID: 32734307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform.
    Vasudevan L; Vandeputte M; Deventer M; Wouters E; Cannaert A; Stove CP
    Biochem Pharmacol; 2020 Jul; 177():113910. PubMed ID: 32179045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological and metabolic characterization of the novel synthetic opioid brorphine and its detection in routine casework.
    Grafinger KE; Wilde M; Otte L; Auwärter V
    Forensic Sci Int; 2021 Oct; 327():110989. PubMed ID: 34509061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alkoxy chain length governs the potency of 2-benzylbenzimidazole 'nitazene' opioids associated with human overdose.
    Glatfelter GC; Vandeputte MM; Chen L; Walther D; Tsai MM; Shi L; Stove CP; Baumann MH
    Psychopharmacology (Berl); 2023 Dec; 240(12):2573-2584. PubMed ID: 37658878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro structure-activity relationships and forensic case series of emerging 2-benzylbenzimidazole 'nitazene' opioids.
    De Vrieze LM; Walton SE; Pottie E; Papsun D; Logan BK; Krotulski AJ; Stove CP; Vandeputte MM
    Arch Toxicol; 2024 Sep; 98(9):2999-3018. PubMed ID: 38877156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole 'nitazene' synthetic opioid.
    Vandeputte MM; Krotulski AJ; Walther D; Glatfelter GC; Papsun D; Walton SE; Logan BK; Baumann MH; Stove CP
    Arch Toxicol; 2022 Jun; 96(6):1845-1863. PubMed ID: 35477798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro functional assays as a tool to study new synthetic opioids at the μ-opioid receptor: Potential, pitfalls and progress.
    Vandeputte MM; Vasudevan L; Stove CP
    Pharmacol Ther; 2022 Jul; 235():108161. PubMed ID: 35183593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne), a recent addition to the 2-benzylbenzimidazole opioid subclass.
    Vandeputte MM; Verougstraete N; Walther D; Glatfelter GC; Malfliet J; Baumann MH; Verstraete AG; Stove CP
    Arch Toxicol; 2022 Jun; 96(6):1865-1880. PubMed ID: 35449307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection, chemical analysis, and pharmacological characterization of dipyanone and other new synthetic opioids related to prescription drugs.
    Vandeputte MM; Walton SE; Shuda SA; Papsun DM; Krotulski AJ; Stove CP
    Anal Bioanal Chem; 2023 Sep; 415(21):5165-5180. PubMed ID: 37173408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First Report on Brorphine: The Next Opioid on the Deadly New Psychoactive Substance Horizon?
    Verougstraete N; Vandeputte MM; Lyphout C; Cannaert A; Hulpia F; Van Calenbergh S; Verstraete AG; Stove C
    J Anal Toxicol; 2021 Jan; 44(9):937-946. PubMed ID: 32744605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, biological, and structural explorations of a series of μ-opioid receptor (MOR) agonists with high G protein signaling bias.
    Yang Y; Wang Y; Zuo A; Li C; Wang W; Jiang W; Zhang X; Che X; Zhang Y; Wu W; Cen X; Wang H; Tian J
    Eur J Med Chem; 2022 Jan; 228():113986. PubMed ID: 34802839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-Efficacy Mu Opioid Agonists as Candidate Analgesics: Effects of Novel C-9 Substituted Phenylmorphans on Pain-Depressed Behavior in Mice.
    Santos EJ; Akbarali HI; Bow EW; Chambers DR; Gutman ES; Jacobson AE; Kang M; Lee YK; Lutz JA; Rice KC; Sulima A; Negus SS
    J Pharmacol Exp Ther; 2024 Oct; 391(2):138-151. PubMed ID: 38637015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of N-desethyl etonitazene in a drug checking sample: Chemical analysis and pharmacological characterization of a recent member of the 2-benzylbenzimidazole "nitazene" class.
    Monti MC; De Vrieze LM; Vandeputte MM; Persson M; Gréen H; Stove CP; Schlotterbeck G
    J Pharm Biomed Anal; 2024 Dec; 251():116453. PubMed ID: 39216307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of novel synthetic opioids (NSO) found in the recreational drug marketplace.
    Baumann MH; Majumdar S; Le Rouzic V; Hunkele A; Uprety R; Huang XP; Xu J; Roth BL; Pan YX; Pasternak GW
    Neuropharmacology; 2018 May; 134(Pt A):101-107. PubMed ID: 28807672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracerebroventricular administration of CYX-6, a potent μ-opioid receptor agonist, a δ- and κ-opioid receptor antagonist and a biased ligand at μ, δ & κ-opioid receptors, evokes antinociception with minimal constipation and respiratory depression in rats in contrast to morphine.
    Imam MZ; Kuo A; Ghassabian S; Cai Y; Qin Y; Li T; Smith MT
    Eur J Pharmacol; 2020 Mar; 871():172918. PubMed ID: 31958457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding preference at the μ-opioid receptor underlies distinct pharmacology of cyclopropyl versus valeryl analogs of fentanyl.
    Xie B; Le Rouzic VP; Goldberg A; Tsai MM; Chen L; Zhang T; Sinha A; Pan YX; Baumann MH; Shi L
    Neuropharmacology; 2023 Apr; 227():109442. PubMed ID: 36731721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro Functional Profiling of Fentanyl and Nitazene Analogs at the μ-Opioid Receptor Reveals High Efficacy for Gi Protein Signaling.
    Tsai MM; Chen L; Baumann MH; Canals M; Javitch JA; Lane JR; Shi L
    ACS Chem Neurosci; 2024 Feb; 15(4):854-867. PubMed ID: 38345920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.